RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer

Baselga, José ; Zamagni, Claudio ; Gómez, Patricia ; Bermejo, Begoña ; Nagai, Shigenori E. ; Melichar, Bohuslav ; Chan, Arlene ; Mángel, Lászlo ; Bergh, Jonas ; Costa, Frederico ; Gómez, Henry L. ; Gradishar, William J. ; Hudis, Clifford A. ; Rapoport, Bernardo L. ; Roché, Henri ; Maeda, Patricia ; Huang, Liping ; Meinhardt, Gerold ; Zhang, Joshua ; Schwartzberg, Lee S.

Clinical breast cancer, 2017-12, Vol.17 (8), p.585-594.e4 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível